Stocks and Investing Stocks and Investing
Mon, January 28, 2019
Fri, January 25, 2019
Thu, January 24, 2019
Wed, January 23, 2019

John Newman Maintained (BLUE) at Strong Buy with Decreased Target to $161 on, Jan 23rd, 2019


Published on 2024-10-26 11:53:06 - WOPRAI, John Newman
  Print publication without navigation


John Newman of Canaccord Genuity, Maintained "bluebird bio, Inc." (BLUE) at Strong Buy with Decreased Target from $250 to $161 on, Jan 23rd, 2019.

John has made no other calls on BLUE in the last 4 months.



There are 2 other peers that have a rating on BLUE. Out of the 2 peers that are also analyzing BLUE, 1 agrees with John's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $125 on, Wednesday, December 19th, 2018


This is the rating of the analyst that currently disagrees with John


  • Michael Schmidt of "Leerink Swann" Initiated at Buy and Held Target at $145 on, Wednesday, November 28th, 2018
Contributing Sources